A collaboration led by
St. Jude Children’s Research Hospital, Shanghai Children’s Medical Center and others revealed how thiopurines produce mutations that lead to multi-drug resistant leukemia and relapse.
Immunologists have determined the process driving life-threatening inflammation, lung damage and organ failure in patients with COVID-19, sepsis and other inflammatory disorders suggesting possible treatment using existing drugs.
Now through Aug. 3, bidding is open for an online auction affiliated with the
St. Jude JAM Presented by Delta Dental of Tennessee and HH Global, a virtual concert event for
St. Jude Children’s Research Hospital® at 5:30 p.m. CT on Tuesday, Aug. 3, at Radians Amphitheater at Memphis Botanic Garden.